We may be a step closer to a highly effective mRNA vaccine against HIV, but tests so far reveal that the approach can cause ...

Results from early-stage trial show that 80% of participants who received one of two HIV vaccine candidates produced antibodies against viral proteins.

HIV vaccine efforts have been slowed by the difficulty of getting neutralizing antibodies to target the correct locations of ...

Several vaccines for HIV have been tested in animal studies and an early safety trial in people, showing promising results in ...

Scientists used a mRNA-based vaccine to reliably trigger antibodies that block HIV infection in people and monkeys ...

The results suggest the possibility of a vaccine for HIV/AIDS, which killed more than half a million people last year.

Previous research has shown that HIV-specific CD8 T-cell responses directed against five genetically conserved HIV-1 protein ...

Photo: belyaaa via 123rf New research employing mRNA technology — which gained prominence during the COVID-19 pandemic — may offer the key to developing a cure for HIV. One of the chief ...

Researchers in Australia have developed a novel lipid nanoparticle, dubbed LNP X, capable of delivering mRNA into white blood cells harboring HIV (pictured here). Corona Borealis – stock.adobe.com ...

HIV researchers in Australia have figured out a way to make the virus visible in white blood cells using mRNA, something that could lead to an eventual cure. Researchers from the Peter Doherty ...